ITGAM and Miyoshi myopathy: In contrast, recent studies demonstrated no difference in the MO-MDSC population, but a significant increase in G-MDSC, defined as CD11b+CD14−CD33+CD15+ (22) or CD11b+CD14−CD33+CD15+HLA-DRlow (12), in BM and peripheral blood of MM patients.